OakChart

Progyny Inc

PGNYHealthcare·Healthcare Plans·USA·Mid·NASD·Nov 11 • 3:59 PM ET

36.50+0.07 (0.19%)
2026-11-12 06:57 CET
Market cap
2,688.13 USD m
Revenue, TTM
1,338.67 USD m
Net income, TTM
91.02 USD m
Free cash flow, TTM
179.64 USD m
EPS diluted, TTM
1.09
P/E
33.47
Compare

Price

PGNY against its 20, 50 and 200-day averages
2050200beat
Patternshover a marker to name it
20.0025.0030.0035.002.2M4.4MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26PGNYclose 36.5020-day 30.2650-day 28.08200-day 24.7036.50

0.1% under the 52-week high of 36.52 on 11 Nov 2026. 52-week low 16.10 on 10 Apr 2026. Last 15 sessions, 32.6% high to low

Volume 0.80× normal · the line is the 50-bar volume average

Profile

PGNY
52-week range, 100% of the way up
16.1036.45

Progyny, Inc. is a fertility benefits management company. It provides fertility solutions to employers, managing IUI, in vitro fertilization (IVF), egg freezing, and other fertility treatments. It operates through one segment: fertility and pharmacy benefits solutions. It also delivers treatment services and access to the firm's network of fertility specialist. The company was founded on April 3, 2008 and is headquartered in New York, NY.

IndexRUT
Employees856
IPOOct 25, 2019
Beta0.91
ATR, 14d1.22
Rel volume0.80
Short float6.65%
Insider own2.85%
Inst own104.39%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap2.69B
Enterprise Value2.52B
Income91.02M
Sales1.34B
Book/sh5.54
Cash/sh2.67
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees856
IPOOct 25, 2019

Ratios

P/E33.47
Forward P/E22.87
PEG0.55
P/S2.01
P/B6.59
P/C13.67
P/FCF14.96
EV/EBITDA19.01
EV/Sales1.88
Quick Ratio1.93
Current Ratio1.93
Debt/Eq0.06
LT Debt/Eq0.05
Option/ShortYes / Yes

Earnings

EPS (ttm)1.09
EPS next Y1.60
EPS next Q0.36
EPS this Y102.62%
EPS next Y21.18%
EPS next 5Y41.75%
EPS past 3/5Y28.95% 6.78%
Sales past 3/5Y17.87% 30.17%
EPS Y/Y TTM74.23%
Sales Y/Y TTM5.52%
EPS Q/Q110.41%
Sales Q/Q8.91%
EarningsNov 04 AMC
EPS/Sales Surpr.2.24% 0.14%

Ownership

Insider Own2.85%
Insider Trans-15.97%
Inst Own104.39%
Inst Trans-3.58%
ROA12.38%
ROE18.69%
ROIC20.89%
Gross Margin24.87%
Oper. Margin9.40%
Profit Margin6.80%
SMA2020.61%
SMA5029.97%
SMA20047.78%
Trades-

Technical

Shs Outstand74.72M
Shs Float71.55M
Short Float6.65%
Short Ratio4.26
Short Interest4.76M
52W High36.45 0.14%
52W Low16.10 126.71%
Volatility4.90% 3.55%
ATR (14)1.22
RSI (14)83.21
Beta0.91
Rel Volume0.80
Avg Volume1.12M
Volume891,172

Performance

Perf Week21.26%
Perf Month33.26%
Perf Quarter40.98%
Perf Half Y55.25%
Perf YTD42.13%
Perf Year53.30%
Perf 3Y20.94%
Perf 5Y-40.07%
Perf 10Y-
Recom1.33
Target Price37.25
Prev Close36.43
Price36.50
Change %0.19%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Aug 20, 2026InitiatedWWells FargoOverweight$37+1.4%
Jul 28, 2026DowngradeBBarclaysOverweight → Equal Weight$34-6.8%
May 19, 2026UpgradeCCanaccord GenuityHold → Buy$30-17.8%
Jan 20, 2026UpgradeCCitizens JMPMkt Perform → Mkt Outperform$30-17.8%
Jan 08, 2026UpgradeTTruistHold → Buy$34-6.8%
Dec 09, 2025InitiatedBBarclaysOverweight$29-20.5%
Nov 12, 2025UpgradeKKeyBanc Capital MarketsSector Weight → Overweight$30-17.8%
Jul 08, 2025UpgradeLLeerink PartnersMarket Perform → Outperform$28-23.3%
Dec 02, 2024DowngradeJJP MorganOverweight → Neutral$17-53.4%
Nov 13, 2024DowngradeTTruistBuy → Hold$26 → $19-47.9%

Peers

Mkt cap
TickerCompanyMkt cap
HNGEHinge Health Inc9.49B
CICigna Group79.43B
OMDAOmada Health Inc945.46M
HQYHealthequity Inc8.52B
EVHEvolent Health Inc564.40M
UNHUnitedhealth Group Inc361.04B
CVSCVS Health Corp114.54B
TDOCTeladoc Health Inc1.63B
IVFINVO Fertility Inc3.21M
NIVFNewGenIvf Group Ltd0.37M

Insider trading

latest 14 of 64
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
ANEVSKI 2026 SOUTH DAKOTA NGCGDirectorNov 10 '26Proposed Sale35.9550,1391,802,497Nov 10 04:30 PM
Anevski PeterCHIEF EXECUTIVE OFFICERNov 09 '26Option Exercise0.91126,204114,846923,776Nov 09 09:57 PM
Anevski PeterCHIEF EXECUTIVE OFFICERNov 05 '26Option Exercise0.913,4003,094809,511Nov 09 09:57 PM
Anevski PeterCHIEF EXECUTIVE OFFICERNov 09 '26Sale35.73161,3085,762,841762,468Nov 09 09:57 PM
Anevski PeterCHIEF EXECUTIVE OFFICERNov 05 '26Sale35.1311,939419,412797,572Nov 09 09:57 PM
Schlanger David JExecutive ChairmanNov 09 '26Option Exercise0.91161,208146,699399,670Nov 09 09:55 PM
Schlanger David JExecutive ChairmanNov 05 '26Option Exercise0.913,4003,094241,862Nov 09 09:55 PM
Schlanger David JExecutive ChairmanNov 09 '26Sale35.73161,2085,759,365238,462Nov 09 09:55 PM
Schlanger David JExecutive ChairmanNov 05 '26Sale35.223,400119,751238,462Nov 09 09:55 PM
Livingston Mark S.CHIEF FINANCIAL OFFICERNov 04 '26Sale30.002,13964,17070,314Nov 06 04:06 PM
DAVID SCHLANGERDirectorNov 05 '26Proposed Sale30.10200,0006,020,000Nov 05 04:30 PM
ANEVSKI 2026 SOUTH DAKOTA NGCGDirectorNov 05 '26Proposed Sale30.1090,0002,709,000Nov 05 04:28 PM
PETER ANEVSKIDirectorNov 05 '26Proposed Sale30.10314,7389,473,614Nov 05 04:27 PM
Livingston Mark S.OfficerNov 04 '26Proposed Sale30.002,13964,170Nov 04 12:22 PM

Held by

AUM
TickerCompanyAUM
IJRiShares Core S&P Small-Cap ETFAUM: 106.27B
AVUVAvantis U.S. Small Cap Value ETFAUM: 32.39B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
SPSMState Street SPDR Portfolio S&P 600TM Small Cap ETFAUM: 16.06B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
IJTiShares S&P Small-Cap 600 Growth ETFAUM: 7.45B
VBKVanguard Morningstar Small-Cap Growth ETFAUM: 22.34B
VXFVanguard Extended Market Index ETFAUM: 30.47B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-040.3200.3130.320341.25340.7610
2026Q22026-08-060.3400.3350.342350.51349.0510
2026Q12026-05-070.2900.2560.286328.5326.4610
2025Q42026-02-260.1400.1470.140318.4307.4210
2025Q32025-11-060.1500.1270.154313.35299.2610
2025Q22025-08-070.1900.1580.191332.87320.19
2025Q12025-05-080.1700.1900.169324.04307.8610
2024Q42025-02-270.1200.0960.118298.43277.7810
2024Q32024-11-120.1100.1430.111286.63296.8511
2024Q22024-08-060.1700.1690.169304.09305.1110
2024Q12024-05-090.1700.1320.167278.08289.4110
2023Q42024-02-270.1300.1080.134269.94274.0810
2023Q32023-11-070.1600.1150.158280.89271.28
2023Q22023-08-030.1500.1030.149279.37261.918
2023Q12023-05-080.1800.0740.177258.39246.437
2022Q42023-02-270.0300.0120.034214.32211.786

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY0.1100.071-0.103229.68230.77
2020FY0.1800.1770.469344.86342.45
2021FY0.6600.5370.655500.62507.85
2022FY0.3000.2820.304786.91784.27
2023FY0.6200.5910.6161,0891,093
2024FY0.5700.5470.5691,1671,147
2025FY0.6500.6590.6501,2891,278
2026FY-1.317--1,377
2027FY-1.596--1,534
2028FY-1.851--1,651
2029FY-1.983--1,644
2030FY-1.940--1,707

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-061122356.15349.07362.78
2026Q4S2026-11-051122355.87349.07362.78
2026Q4S2026-11-041101354.39345.9362.87
2026Q4S2026-10-261101354.39345.9362.87
2026Q4S2026-10-211102354.39345.9362.87
2026Q4S2026-10-161114354.39345.9362.87
2026Q4S2026-10-151123355.1345.9364.61
2026Q4S2026-10-141123355.1345.9364.61
2026Q4S2026-10-071123354.92343.6364.61
2026Q4S2026-10-061123354.92343.6364.61
2026Q4S2026-09-011123354.89343.6364.61
2026Q4S2026-08-201123354.87343.6364.61
2026Q4S2026-08-191133355.15343.6364.61
2026Q4S2026-08-121033355.31343.6364.61

Estimate history

EPS, annual-0.164-0.067-0.1030.4690.6550.3040.6160.5690.6511.0904
Period201720182019202020212022202320242025TTM
EPS, quarterly0.1110.1180.1690.1910.1540.140.2860.3420.323
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual48.584105.4229.683344.858500.621786.9131088.5981167.2211288.6611338.67
Period201720182019202020212022202320242025TTM
Sales, quarterly286.625298.431324.038332.874313.346318.403328.504350.511341.254
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual82.17582.17583.57286.43890.47392.68595.73385.31183.36674.723
Period201720182019202020212022202320242025MRQ
Shares, quarterly88.34385.31185.6785.92886.14783.36678.2777.3974.723
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue1,338.671,288.661,167.221,088.60786.91500.62344.86229.68105.40
Cost of Goods Sold Incl. D&A1,005.68984.18913.86849.80619.59388.49274.80184.1885.97
Gross Profit332.99304.48253.36238.80167.32112.1470.0645.5119.43
Selling, General and Administrative Excl. Other207.21219.21185.91176.62143.9879.8061.7135.8322.89
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income125.7985.2867.4562.1823.3432.348.359.68-3.45
Interest Expense1.000.401.53----0.060.41
Unusual Expense0.000.00-7.30-3.900.000.000.0018.183.03
Net Income Before Taxes132.2995.4383.2070.6924.4432.448.68-8.56-6.89
Income Taxes41.2736.9128.878.65-5.92-33.33-37.780.01-1.78
Consolidated Net Income91.0258.5254.3462.0430.3665.7746.46-8.57-5.12
Net Income From Continuing Operations91.0258.5254.3462.0430.3665.7746.46-8.57-5.12
Net Income91.0258.5254.3462.0430.3665.7746.46-8.57-5.54
EPS (Recurring)1.120.650.520.590.300.660.470.05-0.04
EPS (Basic, Before Extraordinaries)1.150.680.590.650.330.740.54-0.10-0.07
EPS (Diluted)1.090.650.570.620.300.660.47-0.10-0.07
EBITDA132.4190.2270.6364.4724.9433.6410.2511.81-1.57
Non-Operating Income (Expense)7.5010.559.984.611.100.100.330.000.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense75.92104.17101.2296.8679.5924.619.363.692.37
Price To Earnings Ratio33.4733.4729.7271.9074.1076.6690.54--
Price To Sales Ratio1.531.791.413.443.9610.0912.189.99-
Gross Margin24.8723.6321.7121.9421.2622.4020.3219.8118.44
Operating Margin9.406.625.785.712.976.462.424.21-3.28
Net Margin6.804.544.665.703.8613.1413.47-3.73-5.26
Shares Outstanding74.7283.3785.3195.7392.6990.4786.4483.5782.17
Market Capitalization2,688.132,688.131,468.893,563.192,893.314,553.173,672.402,307.062,370.52

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue341.25350.51328.50318.40313.35332.87324.04298.43
Cost of Goods Sold Incl. D&A257.51261.21245.43241.52240.51253.90248.24235.00
Gross Profit83.7489.3083.0776.8872.8378.9775.8063.43
Selling, General and Administrative Excl. Other48.5649.3047.6961.6651.3154.6251.6247.65
Research and Development3.10-------
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income35.1840.0035.3815.2221.5324.3624.1715.79
Interest Expense0.300.300.300.10----
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes36.4241.1436.8817.8523.9627.0826.5417.66
Income Taxes10.1613.0912.655.3710.109.9611.487.13
Consolidated Net Income26.2528.0524.2312.4813.8617.1115.0610.53
Net Income From Continuing Operations26.2528.0524.2312.4813.8617.1115.0610.53
Net Income26.2528.0524.2312.4813.8617.1115.0610.53
EPS (Recurring)0.320.340.290.140.150.190.170.12
EPS (Basic, Before Extraordinaries)0.340.360.300.150.160.200.180.12
EPS (Diluted)0.320.340.290.140.150.190.170.12
EBITDA37.3341.6336.8616.5922.8025.5625.2816.66
Non-Operating Income (Expense)1.531.431.802.732.442.722.371.87
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense16.6716.1815.5827.4925.4225.5825.6824.38
Price To Earnings Ratio33.4737.4426.0240.6636.5438.8339.5329.72
Price To Sales Ratio1.531.811.111.781.531.591.641.31
Gross Margin24.5425.4825.2924.1523.2423.7223.3921.26
Operating Margin10.3111.4110.774.786.877.327.465.29
Net Margin7.698.007.383.924.425.144.653.53
Shares Outstanding74.7277.3978.2783.3786.1585.9385.6785.31
Market Capitalization2,688.132,258.321,390.702,213.921,850.341,885.801,908.131,468.89

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments310.10227.95371.09189.30119.42109.3080.380.134.69
Short Term Receivables220.29235.32241.87240.07134.5675.6647.0623.3211.37
Inventories0.000.000.000.000.000.000.000.000.00
Other Current Assets21.399.4427.454.494.565.265.001.080.71
Total Current Assets551.77472.72640.41433.86258.54190.22132.4424.5416.77
Net Property, Plant & Equipment54.9229.6327.8215.2712.8312.073.080.780.60
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Intangible Assets26.1916.8411.8811.9812.4813.0914.2615.7417.22
Deferred Tax Assets100.5089.9879.8080.9171.2737.97---
Other Assets16.542.983.403.992.940.570.650.270.37
Total Assets749.92612.15763.30546.00358.06253.93150.4341.3234.96
Short Term Debt Incl. Current Port. of LT Debt3.732.862.151.231.230.000.000.253.56
Accounts Payable124.0795.10125.43109.2961.4043.5119.3915.585.13
Other Current Liabilities74.5970.6758.3849.0236.1934.2716.7714.379.08
Total Current Liabilities202.39168.63185.95159.5498.8277.7936.1630.2017.77
Long Term Debt24.0016.4117.246.487.428.320.00106.24109.94
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities7.495.056.683.02-----
Other Liabilities0.000.000.000.000.000.880.000.004.87
Total Liabilities233.88190.09209.88169.03106.2486.9836.16136.44132.58
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity516.04422.06553.43376.97251.82166.95114.27-95.11-97.62
Total Shareholders Equity516.04422.06553.43376.97251.82166.95114.27-95.11-97.62
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity516.04422.06553.43376.97251.82166.95114.27-95.11-97.62
Total Liabilities & Stockholders Equity749.92612.15763.30546.00358.06253.93150.4341.3234.96
Book Value Per Share6.194.955.784.072.781.931.37-1.16-1.19
Tangible Book Value Per Share5.884.755.663.942.651.781.20-1.35-1.40
Full-Time Employees856680566400313210167125-
Price to Book Ratio6.593.506.868.3218.0921.9520.08-25.98-
Return on Assets8.597.909.486.7221.4922.98-8.94-13.41-
Return on Equity12.4811.1413.349.6631.4133.04-89.47--
Return on Invested Capital10.8412.3910.877.9225.3726.51-7.50-46.00-101.06
Quick Ratio2.732.803.442.722.622.453.660.810.94
Current Ratio2.732.803.442.722.622.453.660.810.94

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income91.0258.5254.3462.0430.3665.7746.46-8.57-2.08
Depreciation6.624.953.172.281.601.301.912.131.88
Other Funds (Non Cash)116.90152.04143.82138.18114.5443.5318.4624.843.90
Funds from Operations206.42207.39190.88206.24139.8977.2928.8518.421.92
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital0.762.80-11.78-17.42-59.49-51.267.35-19.950.35
Cash from Operating Activities207.18210.19179.10188.8180.3926.0436.20-1.532.27
Capital Expenditures-27.55-18.41-5.41-3.64-3.24-2.13-1.04-2.96-0.58
Net Assets From Acquisitions0.00-9.34-5.300.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.000.00
Purchase or Sale of Investments130.93-131.26206.50-196.88-40.6210.89-38.990.000.00
Purchase of Investments-77.61-354.96-170.34-429.69-163.33-111.48-103.960.000.00
Sale Or Maturity of Investments208.54223.70376.84232.81122.71122.3764.970.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.202.48
Cash from Investing Activities103.39-159.01195.79-200.53-43.878.77-40.03-2.761.90
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-311.55-80.43-297.886.134.224.272.6884.80-3.64
Repurchase of Common Pref Stock-313.06-81.66-300.280.000.000.000.00-0.18-3.71
Sale of Common Pref Stock1.511.232.406.134.224.272.6884.980.07
Proceedsfrom Stock Options0.000.000.000.000.000.00-0.8978.390.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.000.00-0.25-5.10
Change in Long Term Debt0.000.000.000.000.000.000.00-0.25-5.10
Issuance of Long Term Debt0.000.000.000.000.000.000.00182.0364.42
Reduction of Long Term Debt0.000.000.000.000.000.000.00-182.28-69.52
Net Financing Active Other Cash Flow-20.12-18.93-12.00-17.20-12.09-17.97-8.930.000.00
Other Financing Activities Uses-20.12-18.93-12.00-17.20-12.09-17.97-8.930.000.00
Cash from Financing Activities-331.67-99.36-309.88-11.07-7.86-13.70-6.2584.55-8.74
Exchange Rate Effect-0.080.060.000.00-----
Net Change in Cash-21.18-48.1265.02-22.7828.6621.11-10.0880.25-4.56
Free Cash Flow179.64191.78173.70185.1777.1523.9135.17-4.491.69
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.00-
Price to Free Cash Flow11.3812.039.4820.2140.36211.35119.40--
Deferred Taxes & Investment Tax Credit--8.12-10.463.75-6.62-33.30-37.970.01-1.78

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments196.64236.93226.15310.10345.21305.09
Short Term Receivables249.18257.48263.61220.29252.50271.85
Inventories0.000.000.000.000.000.00
Other Current Assets18.5818.6211.7921.3924.3017.46
Total Current Assets464.40513.02501.55551.77622.01594.40
Net Property, Plant & Equipment73.1265.5759.9854.9250.4246.37
Total Investments and Advances0.930.000.930.000.000.00
Intangible Assets25.3625.6025.8526.1926.3926.61
Deferred Tax Assets93.0893.0893.08100.5084.8784.94
Other Assets18.9018.5716.9516.5411.538.63
Total Assets675.79715.84698.34749.92795.23760.95
Short Term Debt Incl. Current Port. of LT Debt4.134.474.033.733.423.12
Accounts Payable148.00152.05157.83124.07123.09140.52
Income Tax Payable2.35-----
Other Current Liabilities85.5583.5673.8974.5983.9876.78
Total Current Liabilities240.04240.08235.74202.39210.49220.42
Long Term Debt21.7322.5023.2524.0024.7325.50
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities---7.49--
Other Liabilities0.000.000.000.000.000.00
Total Liabilities261.76262.58258.99233.88235.22245.93
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity414.03453.26439.34516.04560.00515.02
Total Shareholders Equity414.03453.26439.34516.04560.00515.02
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity414.03453.26439.34516.04560.00515.02
Total Liabilities & Stockholders Equity675.79715.84698.34749.92795.23760.95
Book Value Per Share5.545.865.616.196.505.99
Tangible Book Value Per Share5.205.535.285.886.195.68
Full-Time Employees---856--
Price to Book Ratio6.595.142.743.953.594.03
Return on Assets12.3810.659.488.597.777.28
Return on Equity18.6916.2414.9312.4811.3710.94
Return on Invested Capital6.025.905.242.312.373.17
Quick Ratio1.932.142.132.732.962.70
Current Ratio1.932.142.132.732.962.70

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income26.2528.0524.2312.4813.8617.11
Depreciation2.151.621.481.371.271.21
Other Funds (Non Cash)25.2426.3225.6439.7036.3236.66
Funds from Operations53.6556.0151.3645.4151.4654.99
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital2.96-5.58-5.418.80-0.790.52
Cash from Operating Activities56.6050.4245.9554.2050.6755.51
Capital Expenditures-9.37-6.22-6.35-5.61-4.68-5.27
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments4.359.77102.9413.87-38.06-24.65
Purchase of Investments-34.160.000.00-43.45-111.42-54.28
Sale Or Maturity of Investments38.519.77102.9457.3273.3629.63
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-5.023.5596.598.26-42.74-29.91
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-81.86-30.19-118.27-81.230.230.28
Repurchase of Common Pref Stock-82.25-30.55-118.61-81.660.000.00
Sale of Common Pref Stock0.390.360.340.430.230.28
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow-5.54-2.70-4.84-7.03-5.71-2.61
Other Financing Activities Uses-5.54-2.70-4.84-7.03-5.71-2.61
Cash from Financing Activities-87.40-32.89-123.11-88.26-5.49-2.33
Exchange Rate Effect0.01-0.05-0.050.01-0.000.04
Net Change in Cash-35.8021.0319.38-25.792.4423.30
Free Cash Flow47.2444.2139.6048.5945.9950.24
Price to Free Cash Flow11.3813.287.8011.9810.0410.37

Revenue breakdown

Fertility benefit services revenue2024: 729.55M 2025: 830.93M
Pharmacy benefit services revenue2024: 437.67M 2025: 457.73M
United States2024: 1.17B 2025: 1.29B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-306.65%4.8M71.6M1.10M
2026-10-156.51%4.8M74.5M1.13M
2026-09-306.83%5.1M74.5M1.15M
2026-09-156.32%4.7M74.5M1.18M
2026-08-315.97%4.5M74.5M1.25M
2026-08-146.13%4.6M74.6M1.34M
2026-07-315.89%4.5M76.1M1.46M
2026-07-156.68%4.6M69.3M1.51M
2026-06-306.49%4.5M69.3M1.51M
2026-06-156.96%4.8M69.1M1.48M
2026-05-297.32%5.1M69.4M1.57M
2026-05-157.79%5.4M69.6M1.59M
2026-04-309.01%6.3M70.0M1.49M
2026-04-158.42%5.5M65.7M1.53M
2026-03-318.86%6.1M68.7M1.56M
2026-03-138.20%5.6M68.7M1.58M
2026-02-277.50%5.2M68.7M1.46M
2026-02-135.55%4.0M72.3M1.46M
2026-01-303.94%2.8M72.3M1.58M
2026-01-155.07%3.7M72.3M1.66M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.5032.5035.800.0021.7210.000.000.997-0.0200.000
call5.0030.0033.3029.0013.2693.000.000.996-0.0210.001
call7.5027.5030.800.0010.1780.000.000.995-0.0220.001
call10.0025.0028.3018.008.3010.000.000.994-0.0220.001
call12.5022.5025.9014.307.1011.000.000.993-0.0220.001
call15.0020.1023.4012.366.03738.000.000.991-0.0220.001
call17.5017.7020.808.805.05845.000.000.990-0.0220.002
call20.0015.3018.3010.634.32847.000.000.988-0.0210.002
call22.5012.8016.106.453.93317.000.000.985-0.0210.002
call25.0010.6013.109.303.0351320.000.981-0.0210.003
call30.006.007.606.501.6472,22715.000.824-0.1330.015
call35.000.453.100.901.0164552.000.657-0.0980.021
call40.000.000.250.200.5553702.000.165-0.0460.014
call45.000.002.150.040.9872.000.000.100-0.0560.010
put2.500.000.050.007.4580.000.00-0.003-0.0180.000
put5.000.000.050.005.4410.000.00-0.004-0.0180.001
put7.500.002.150.064.56345.000.00-0.005-0.0210.001
put10.000.002.150.053.7547.000.00-0.006-0.0210.001
put12.500.002.150.053.1376.000.00-0.007-0.0200.001
put15.000.002.151.302.6352.000.00-0.009-0.0200.001
put17.500.002.150.122.21319.000.00-0.010-0.0200.002
put20.000.002.150.471.8461.000.00-0.012-0.0190.002
put22.500.002.150.101.52058.000.00-0.015-0.0190.002
put25.000.000.050.151.2255030.00-0.019-0.0180.003
put30.000.000.950.051.56768.000.00-0.176-0.1290.015
put35.000.000.951.700.7231.000.00-0.343-0.0940.021
put40.002.504.900.001.2000.000.00-0.835-0.0420.014
put45.007.8010.5013.702.0810.000.00-0.900-0.0510.010

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-10144Filing for proposed sale of securities under Rule 144.SEC
2026-11-094Statement of changes in beneficial ownership of securities2026-11-05SEC
2026-11-094Statement of changes in beneficial ownership of securities2026-11-05SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-05144Filing for proposed sale of securities under Rule 144.SEC
2026-11-05144Filing for proposed sale of securities under Rule 144.SEC
2026-11-05144Filing for proposed sale of securities under Rule 144.SEC
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-04144Filing for proposed sale of securities under Rule 144.SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-10-27SCHEDULE 13G/ASEC
2026-10-164Statement of changes in beneficial ownership of securities2026-10-14SEC
2026-10-14144Filing for proposed sale of securities under Rule 144.SEC
2026-09-284Statement of changes in beneficial ownership of securities2026-09-23SEC
2026-09-23144Filing for proposed sale of securities under Rule 144.SEC
2026-09-214Statement of changes in beneficial ownership of securities2026-09-17SEC
2026-09-184/A2026-09-10SEC
2026-09-144Statement of changes in beneficial ownership of securities2026-09-10SEC
2026-09-10144Filing for proposed sale of securities under Rule 144.SEC
2026-09-084Statement of changes in beneficial ownership of securities2026-09-03SEC
2026-09-084Statement of changes in beneficial ownership of securities2026-09-03SEC
2026-09-084Statement of changes in beneficial ownership of securities2026-09-04SEC
2026-09-044Statement of changes in beneficial ownership of securities2026-09-02SEC
2026-09-014Statement of changes in beneficial ownership of securities2026-08-28SEC
2026-08-0710-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-068-KCurrent report2026-08-06SEC
2026-08-06SCHEDULE 13G/ASEC
2026-07-164Statement of changes in beneficial ownership of securities2026-07-14SEC
2026-07-14144Filing for proposed sale of securities under Rule 144.SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110012.13M5
2026-100052.61K1
2026-0900423.23K2
2026-080000
2026-070070.91K1
2026-0600351.93K6
2026-0500648.96K4
2026-040000
2026-0300129.51K3
2026-020000
2026-010000
2025-120030.17K3
2025-111.93M1607.66K2

Institutional holders

Manager% owned
BlackRock, Inc.14.81%
FMR LLC9.37%
VANGUARD PORTFOLIO MANAGEMENT LLC6.41%
VANGUARD CAPITAL MANAGEMENT LLC4.10%
STATE STREET CORP3.86%
AMERIPRISE FINANCIAL INC3.53%
GEODE CAPITAL MANAGEMENT, LLC3.26%
DIMENSIONAL FUND ADVISORS LP2.31%
CITADEL ADVISORS LLC2.28%
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/2.13%

Funds

Fund% owned
iShares Core S&P Small-Cap ETF5.60%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.86%
Touchstone Strategic Trust-Touchstone Small Company Fund2.48%
iShares Russell 2000 ETF2.24%
Avantis U.S. Small Cap Value ETF2.16%
Fidelity Small Cap Growth Fund2.14%
VANGUARD SMALL-CAP INDEX FUND2.06%
VANGUARD SMALL-CAP GROWTH INDEX FUND1.18%
Fidelity Small Cap Growth K6 Fund1.08%
VANGUARD EXTENDED MARKET INDEX FUND1.07%

OakChart. PGNY. Cached 15 minutes.